Follow
Swathi Ayloo
Swathi Ayloo
Harvard Medical School
Verified email at hms.harvard.edu
Title
Cited by
Cited by
Year
Development and cell biology of the blood-brain barrier
UH Langen, S Ayloo, C Gu
Annual review of cell and developmental biology 35, 591-613, 2019
3062019
Transcytosis at the blood–brain barrier
S Ayloo, C Gu
Current opinion in neurobiology 57, 32-38, 2019
2022019
Codon adaptation–based control of protein expression in C. elegans
S Redemann, S Schloissnig, S Ernst, A Pozniakowsky, S Ayloo, ...
Nature methods 8 (3), 250-252, 2011
1782011
Dynactin functions as both a dynamic tether and brake during dynein-driven motility
S Ayloo, JE Lazarus, A Dodda, M Tokito, EM Ostap, ELF Holzbaur
Nature communications 5 (1), 4807, 2014
1102014
Optogenetic control of organelle transport using a photocaged chemical inducer of dimerization
ER Ballister, S Ayloo, DM Chenoweth, MA Lampson, ELF Holzbaur
Current Biology 25 (10), R407-R408, 2015
812015
Pericyte-to-endothelial cell signaling via vitronectin-integrin regulates blood-CNS barrier
S Ayloo, CG Lazo, S Sun, W Zhang, B Cui, C Gu
Neuron 110 (10), 1641-1655. e6, 2022
522022
Dynein efficiently navigates the dendritic cytoskeleton to drive the retrograde trafficking of BDNF/TrkB signaling endosomes
S Ayloo, P Guedes-Dias, AE Ghiretti, ELF Holzbaur
Molecular biology of the cell 28 (19), 2543-2554, 2017
392017
Reconstitution of microtubule-based motility using cell extracts
S Ayloo, ELF Holzbaur
Methods in Cell Biology 128, 57-68, 2015
32015
AAV-ARSA mediated gene replacement for the treatment of metachromatic leukodystrophy
S Ramachandran, J Ardinger, MA Ramos, L Guo, M Hossain, S Ayloo, ...
Molecular Genetics and Metabolism 141 (2), 108012, 2024
2024
Evaluation of a novel AAV capsid with widespread CNS and peripheral biodistribution in non-human primates
S Ramachandran, J Hogestyn, S Ayloo, J Ryu, J Ardinger, MA Ramos, ...
Molecular Genetics and Metabolism 141 (2), 108013, 2024
2024
Methods for regulating blood-central nervous system (blood-cns) barrier and uses thereof
S Ayloo, GU Chenghua
US Patent App. 18/296,350, 2023
2023
AAV-ARSA-mediated gene replacement for the treatment of metachromatic leukodystrophy
S Ramachandran, J Ardinger, J Bu, S Ayloo, AM Richards, E WIschhof, ...
Molecular Genetics and Metabolism 138 (2), 107284, 2023
2023
Using single nuclear RNAseq to assess impact of AAV-ARSA gene therapy on oligodendrocyte populations
Y Huang, S Ramachandran, S Ayloo, J Ardinger, D Liu, J Gans, ...
Molecular Genetics and Metabolism 138 (2), 107156, 2023
2023
AAV-ARSA mediated gene replacement for the treatment of Metachromatic Leukodystrophy
M Goulet, S Ramachandran, J Ardinger, J Bu, Y Luo, S Ayloo, L Quigley, ...
HUMAN GENE THERAPY 33 (23-24), A93-A93, 2022
2022
AAV-ARSA Mediated Gene Replacement for the Treatment of Metachromatic Leukodystrophy
S Ramachandran, J Ardinger, J Bu, Y Luo, S Ayloo, L Quigley, A Richards, ...
MOLECULAR THERAPY 30 (4), 30-31, 2022
2022
Pericyte-derived vitronectin regulates blood-CNS barrier function via integrin signaling
S Ayloo, CG Lazo, S Sun, W Zhang, B Cui, C Gu
bioRxiv, 2021.04. 22.441019, 2021
2021
Molecular and cellular approaches toward understanding dynein-driven motility
S Ayloo
University of Pennsylvania, 2016
2016
Dynactin Functions as Both a Dynamic Tether and Brake during Dynein-Driven Motility
S Ayloo, JE Lazarus, A Dodda, M Tokito, EM Ostap, E Holzbaur
Biophysical Journal 108 (2), 135a, 2015
2015
Optogenetic approaches in neurons reveal differential axo-dendritic regulation of motor proteins.
S Ayloo, EL Holzbaur
MOLECULAR BIOLOGY OF THE CELL 26, 2015
2015
Single molecule imaging of neuronal dynein-GFP complex shows bidirectional runs with frequent switching from processive to diffusive motility.
S Ayloo, A Twelvetrees, E Holzbaur
MOLECULAR BIOLOGY OF THE CELL 24, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20